跨境通(002640.SZ):持股5%以上股東徐佳東擬將4.5%股份分割予李俊秋
格隆匯2月17日丨跨境通(002640.SZ)公佈,公司於2020年2月17日接到公司持股5%以上股東徐佳東的通知,其與李俊秋已辦理了解除婚姻關係手續,並與李俊秋就離婚股份分割等事宜做出相關安排。根據徐佳東提供的《通知函》,徐佳東與李俊秋解除了婚姻關係,雙方簽署了《財產分割協議》,協議約定股份分割的具體安排如下:
徐佳東持有的2.37億股跨境通股份中,將7011.18萬股股份(佔公司總股份的4.50%,均為無限售流通股)分割予李俊秋,並將於12個月內辦理完成上述7011.18萬股股份的過户手續。
此次權益變動後,徐佳東仍為公司持股5%以上的股東。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.